Showing 2,021 - 2,040 results of 102,906 for search '(( 5 ((((nm decrease) OR (we decrease))) OR (a decrease)) ) OR ( 2 step decrease ))', query time: 1.85s Refine Results
  1. 2021
  2. 2022

    rVλ6Wil fibrils cause a decrease in cardiomyocytes MTT reduction without inducing cell death. by Helen P. McWilliams-Koeppen (116503)

    Published 2015
    “…(C) Cell number, quantified using crystal violet (black) did not decrease over 72 h of incubation with 1 μM rVλ6Wil fibrils despite a decrease in MMT reduction (grey; n = 3 samples per time point). …”
  3. 2023
  4. 2024
  5. 2025
  6. 2026
  7. 2027

    Stepped-Wedge Trial Diagram. by Sugy Choi (800862)

    Published 2025
    “…</p><p>Methods and analysis</p><p>The QM2-RC encompasses three interconnected projects (Project 1, 2, and 3) aimed at developing a quality management strategy and evaluating its impact on system performance across New York State. …”
  8. 2028
  9. 2029
  10. 2030
  11. 2031
  12. 2032

    Table_1_Elevated hypertriglyceridemia and decreased gallstones in the etiological composition ratio of acute pancreatitis as affected by seasons and festivals: A two-center real-wo... by Wenhua He (5721077)

    Published 2022
    “…The composition ratio of HTG-AP increased, while gallstone AP decreased in winter and in months with long holidays (all P<0.01). …”
  13. 2033
  14. 2034
  15. 2035

    Pharmacological Mechanism of the Non-hallucinogenic 5‑HT<sub>2A</sub> Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

    Published 2022
    “…Compared to DOM, Ariadne shows lower signaling potency and efficacy in multiple signaling pathways examined (G<sub>q</sub>, G<sub>11</sub>, and β-arrestin2) coupled to 5-HT<sub>2A</sub> receptors. We confirmed the shift in signaling for an α-propyl analog and provide a molecular docking rationale for the progressive decrease in signaling potency with the growing length of the α-substituent. …”
  16. 2036

    Pharmacological Mechanism of the Non-hallucinogenic 5‑HT<sub>2A</sub> Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

    Published 2022
    “…Compared to DOM, Ariadne shows lower signaling potency and efficacy in multiple signaling pathways examined (G<sub>q</sub>, G<sub>11</sub>, and β-arrestin2) coupled to 5-HT<sub>2A</sub> receptors. We confirmed the shift in signaling for an α-propyl analog and provide a molecular docking rationale for the progressive decrease in signaling potency with the growing length of the α-substituent. …”
  17. 2037

    DataSheet_2_Decreased expression of SCARA5 predicts a poor prognosis in melanoma using bioinformatics analysis.xlsx by Qinggan Ni (14835463)

    Published 2023
    “…Background<p>It has been established that the scavenger receptor class A member 5 (SCARA5) functions as a tumor suppressor gene in various cancer types. …”
  18. 2038

    DataSheet_3_Decreased expression of SCARA5 predicts a poor prognosis in melanoma using bioinformatics analysis.xlsx by Qinggan Ni (14835463)

    Published 2023
    “…Background<p>It has been established that the scavenger receptor class A member 5 (SCARA5) functions as a tumor suppressor gene in various cancer types. …”
  19. 2039
  20. 2040

    DataSheet_1_Decreased expression of SCARA5 predicts a poor prognosis in melanoma using bioinformatics analysis.xlsx by Qinggan Ni (14835463)

    Published 2023
    “…Background<p>It has been established that the scavenger receptor class A member 5 (SCARA5) functions as a tumor suppressor gene in various cancer types. …”